We are thrilled to announce that Authenticx has successfully raised $24,400,000 in its latest funding round, a significant milestone that will accelerate our mission of revolutionizing healthcare communication. Founded with the vision to help the healthcare industry truly listen at scale, Authenticx leverages advanced AI technology to transform conversations into actionable insights. By harnessing the power of data-driven analysis, we aim to unveil transformational opportunities that drive improved patient outcomes and operational efficiency. With a seasoned leadership team boasting over 100 years of combined experience across pharma, payer, and healthcare organizations, we bring invaluable insights into the complex challenges and opportunities our clients face. The recent funding will not only bolster our technological capabilities but also enhance our ability to meet the growing demand for insightful, real-time analytics in healthcare. Following our recognition as one of America and Indiana's fastest-growing private companies in 2023 on the Inc. 5000, we are energized to build on this momentum. The investment will enable us to expand our product offerings, increase our team, and deepen our commitment to delivering unparalleled insights to our clientele. We are fervently dedicated to driving positive change in the healthcare landscape, and this funding will play a pivotal role in our mission to empower organizations to make informed decisions and achieve their strategic goals. Thank you for your continued support as we embark on this exciting journey towards transforming healthcare listening.
Authenticx Secures $24.4 Million Funding in Series B Round to Revolutionize Healthcare Conversations with AI
Get the full Authenticx company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Digital Asset
Digital Asset is a leading innovator in blockchain technology, transforming traditional and digital financial markets with privacy-enabled solutions that improve capital flow and create a more efficient, fair, and resilient global system. As the creator of the technology that launched the Canton Network, the only public layer one blockchain with privacy, and a founding member of its Global Synchronizer Foundation, Digital Asset has been a pioneer of this open, secure, and interoperable infrastructure. Founded in 2014, Digital Asset is committed to reshaping the future of finance by enabling real-time efficiencies, 24/7 global transactions, and unlocking the full potential of cryptocurrencies, digital assets, and the continued convergence of decentralized and traditional finance. In 2025, Digital Asset was included as a Unicorn in the World Economic Forum’s prestigious Innovator Communities.
$300.0M Unknown
today
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Isomorphic Labs United Kingdom | Series b | $2.1B | today |
| 2 |  Invert Robotics Ireland | Series b | $2.7M | today |
| 3 |  Catch Co. United States | Series b | $38.0M | today |
| 4 |  Tarsus Pharmaceuticals, Inc. United States | Series b | $60.0M | today |
| 5 |  Aclaris Therapeutics, Inc. United States | Series b | $21.0M | today |